UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 27, 2019
Accession Number: 0001144204-19-008163
Submission Type: POS AM
CIK: 0001649989
Company Name: Outlook Therapeutics, Inc.
File Number: 333-209011